Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan for ARDS Prognosis Improvement
NCT04020003Phase 3Unknown
- Sponsor
- Shenzhen Second People's Hospital
- Start
- Jul 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levosimendan in acute respiratory distress syndrome (ARDS), sponsored by Shenzhen Second People's Hospital. Status: unknown.
02
Drugs
levosimendan
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04020003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04020003.